Cargando…

Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines

BACKGROUND: Soft-tissue sarcomas (STS) are a diverse group of malignancies that remain a diagnostic and therapeutic challenge. Relatively few reliable cell lines currently exist. Rapidly developing technology for genomic profiling with emerging insights into candidate functional (driver) aberrations...

Descripción completa

Detalles Bibliográficos
Autores principales: Salawu, Abdulazeez, Fernando, Malee, Hughes, David, Reed, Malcolm W R, Woll, Penella, Greaves, Claire, Day, Chris, Alhajimohammed, Meshal, Sisley, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117779/
https://www.ncbi.nlm.nih.gov/pubmed/27560552
http://dx.doi.org/10.1038/bjc.2016.259
_version_ 1782468866729836544
author Salawu, Abdulazeez
Fernando, Malee
Hughes, David
Reed, Malcolm W R
Woll, Penella
Greaves, Claire
Day, Chris
Alhajimohammed, Meshal
Sisley, Karen
author_facet Salawu, Abdulazeez
Fernando, Malee
Hughes, David
Reed, Malcolm W R
Woll, Penella
Greaves, Claire
Day, Chris
Alhajimohammed, Meshal
Sisley, Karen
author_sort Salawu, Abdulazeez
collection PubMed
description BACKGROUND: Soft-tissue sarcomas (STS) are a diverse group of malignancies that remain a diagnostic and therapeutic challenge. Relatively few reliable cell lines currently exist. Rapidly developing technology for genomic profiling with emerging insights into candidate functional (driver) aberrations raises the need for more models for in vitro functional validation of molecular targets. METHODS: Primary cell culture was performed on STS tumours utilising a differential attachment approach. Cell lines were characterised by morphology, immunocytochemistry, proliferation assays, short tandem repeat (STR) and microarray-based genomic copy number profiling. RESULTS: Of 47 STS cases of various subtypes, half formed adherent monolayers. Seven formed self-immortalised cell lines, including three undifferentiated pleomorphic sarcomas, two dedifferentiated liposarcomas (one of which had received radiotherapy), a leiomyosarcoma and a myxofibrosarcoma. Two morphologically distinct yet genetically identical variants were established in separate cultures for the latter two tumours. All cell lines demonstrated genomic and phenotypic features that not only confirm their malignant characteristics but also confirm retention of DNA copy number aberrations present in their parent tumours that likely include drivers. CONCLUSIONS: These primary cell lines are much-needed additions to the number of reliable cell lines of STS with complex genomics available for initial functional validation of candidate molecular targets.
format Online
Article
Text
id pubmed-5117779
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-51177792017-10-25 Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines Salawu, Abdulazeez Fernando, Malee Hughes, David Reed, Malcolm W R Woll, Penella Greaves, Claire Day, Chris Alhajimohammed, Meshal Sisley, Karen Br J Cancer Translational Therapeutics BACKGROUND: Soft-tissue sarcomas (STS) are a diverse group of malignancies that remain a diagnostic and therapeutic challenge. Relatively few reliable cell lines currently exist. Rapidly developing technology for genomic profiling with emerging insights into candidate functional (driver) aberrations raises the need for more models for in vitro functional validation of molecular targets. METHODS: Primary cell culture was performed on STS tumours utilising a differential attachment approach. Cell lines were characterised by morphology, immunocytochemistry, proliferation assays, short tandem repeat (STR) and microarray-based genomic copy number profiling. RESULTS: Of 47 STS cases of various subtypes, half formed adherent monolayers. Seven formed self-immortalised cell lines, including three undifferentiated pleomorphic sarcomas, two dedifferentiated liposarcomas (one of which had received radiotherapy), a leiomyosarcoma and a myxofibrosarcoma. Two morphologically distinct yet genetically identical variants were established in separate cultures for the latter two tumours. All cell lines demonstrated genomic and phenotypic features that not only confirm their malignant characteristics but also confirm retention of DNA copy number aberrations present in their parent tumours that likely include drivers. CONCLUSIONS: These primary cell lines are much-needed additions to the number of reliable cell lines of STS with complex genomics available for initial functional validation of candidate molecular targets. Nature Publishing Group 2016-10-25 2016-08-25 /pmc/articles/PMC5117779/ /pubmed/27560552 http://dx.doi.org/10.1038/bjc.2016.259 Text en Copyright © 2016 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/4.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
spellingShingle Translational Therapeutics
Salawu, Abdulazeez
Fernando, Malee
Hughes, David
Reed, Malcolm W R
Woll, Penella
Greaves, Claire
Day, Chris
Alhajimohammed, Meshal
Sisley, Karen
Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines
title Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines
title_full Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines
title_fullStr Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines
title_full_unstemmed Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines
title_short Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines
title_sort establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines
topic Translational Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5117779/
https://www.ncbi.nlm.nih.gov/pubmed/27560552
http://dx.doi.org/10.1038/bjc.2016.259
work_keys_str_mv AT salawuabdulazeez establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines
AT fernandomalee establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines
AT hughesdavid establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines
AT reedmalcolmwr establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines
AT wollpenella establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines
AT greavesclaire establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines
AT daychris establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines
AT alhajimohammedmeshal establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines
AT sisleykaren establishmentandmolecularcharacterisationofsevennovelsofttissuesarcomacelllines